To avoid unexpected SAA results it is critical to understand basic SAA biology and interpret results in light of other clinical data.

The dynamic nature of SAA makes it an ideal marker for monitoring progression or resolution of illness, including response to treatment.

In 1995, when we first tested the Clostridium chauvoei antiserum that serves as the raw material for our C. chauvoei conjugate